Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

310

HTML

1795

Figures (1-3)

280

Tables (1-6)

208

Sum=2593

Apr 7, 2007 (publication date) through Dec 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Apr 7, 2007; 13(13): 1983-1988
Published online Apr 7, 2007. doi: 10.3748/wjg.v13.i13.1983

Table 6 ICAM-1 expression in acinar cells of the pancreas (mean ± SE)

^aP < 0.05,

^bP < 0.01 vs sham,

^cP < 0.05 vs PP,

^eP < 0.05 vs 3 h.

Citation: Xu P, Zhou XJ, Chen LQ, Chen J, Xie Y, Lv LH, Hou XH. Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis. World J Gastroenterol 2007; 13(13): 1983-1988
URL: https://www.wjgnet.com/1007-9327/full/v13/i13/1983.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i13.1983